Amid recent Chinese covid outbreaks in March and April Yiling's market capitalisation surpassed $11bn.

在最近的 3 月和 4 月中国爆发新冠疫情期间，以岭的市值超过 110 亿美元。

In 2021 sales of Yiling Pharmaceutical, a big maker of traditional Chinese medicines including lianhua qingwen, used against covid, among various other ailments, exceeded 10bn yuan ($1.6bn), nearly double the figure in pre-pandemic 2019.

2021 年， 以岭药业是一家大型中药生产商，用于治疗新冠肺炎和其他各种疾病的连花清瘟等中药的销售额超过 100 亿元人民币（ 16 亿美元） ， 几乎是 2019 年大流行前的两倍。